Matteo Droghetti

Read European Urology Oncology's latest article published online, by Lorenzo Bianchi et al. Thank you for your contribution! Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology—Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study Explore the full study at: euoncology.europeanurology.com/article/S2588-… @Lorenzo26232839 @drMDrog @cal_Catanzaro @MRoupret @CaPsurvivorshop @Ric_Campi @jteoh_hk @UroDocAsh @Uroweb @F_Montorsi @Albert0Briganti @ClaudiaKesch @roodvdb @riccardosciav6 @dr_rajwa #UroOncology #ProstateCancer #MensHealth #eau #YAU #urologist

@VickersBiostats Still calling cancer something that not a single urologist wants to find in any biopsy specimen, and that comes only with problems for the patients first and also for healthcare costs linked to AS , still drives me crazy as Urologist

"Patients with grade group (GG) 1 on biopsy can have higher grade disease on surgery. So GG1 = cancer". But also true of benign: "Patients with benign on biopsy can have higher grade disease on surgery"

@VickersBiostats 100% agree. For PLND detractors The Gandaglia nomogram represents a good tool for opt-in or out from PLND in low volume HR PCa, sparing a significant number of unnecessary PLNDs while still chasing for significant pN+. We just need to use the right tools for decision making

Major systematic review on PSMA PET in prostate cancer concludes "PSMA PET cannot be used alone to determine the need for lymph node dissection (LND)." Time to end the practice of negative PSMA PET = no LND sciencedirect.com/science/articl…

@VickersBiostats @veerukasi @JAMA_current doi.org/10.1016/j.euro… microUS could possibly do that, still it remains quite operator dependent

@veerukasi @JAMA_current Question: can micro US be used to avoid biopsy i.e. no lesion found on micro US, don't do biopsy?

🚨OPTIMUM trial results #EAU25 Multicentre RCT (n=802) MRI-TB vs MicroUS vs MicroUS+MRI-TB in men with suspected PCa. MicroUS non-inferior for GG2 detection. Possible alternative to MRI-TB? Copublished in @JAMA_current jamanetwork.com/journals/jama/…

Urology of Bologna involved in intensive presentations at EAU25 #Madrid @Uroweb @Unibo

Great to see published our efforts made during the period at @NKI_nl ! Kudos to @oktyzmn and all the team!!!

How important is knowledge of anatomy for the surgeons of the next gen? learn with the brightest young urologists and anatomists at the university of bologna @Eugenio74446325 @aleantonellibs1 @minerviniandre @agalfano @pietropiazza @paolo_delloglio @GGandaglia @RicBertolo @andreamari08 @AngeloMottaran @drMDrog

Great to see on @JUrology out results on oncological outcomes of sentinel node location in prostate cancer! @NKI_nl @oktyzmn @hvdpoel @riccardoschiav6 @Eugenio74446325 Check out the PDF at jurology.com/eprint/MK8SRHS…

@oktyzmn @so_uro @AcademicOner @ytanidir @halukakpinar @drcaydin @barbaroza @bulonal @DrHakanCakirUro @spongios @EAU_YAUProstate @alexmottrie @AlbertoBreda1 @Tilki_De @FraClaps @RobertoContieri Bx done transrect/transper or was it via TUR? BTW unsure about what’s the best management in this case. RC given the mesenchymal nature of the tumor or RP?

What is your opinion #urosome @so_uro @AcademicOner @ytanidir @halukakpinar @drcaydin @barbaroza @bulonal @DrHakanCakirUro @spongios @EAU_YAUProstate @alexmottrie @AlbertoBreda1 @Tilki_De @FraClaps @drMDrog @RobertoContieri

47 y/o male with chronic constipation and bilateral hydronephrosis+uremia. PSA: 1.2 ng/dL.

Catching up some reading & good to see initial conclusions confirmed in longer term results, that adj RT after RP doesn’t improve FFDM or OS & ⬆️ toxicity compared to salvage. There is slight curve sep at 10 years for FFDM with p = 0.09 but seems unlikely to become clinically relevant. secure.jbs.elsevierhealth.com/action/getShar…

❓Could PSMA expression on PCa biopsy cores help select patients for PSMA pet? ▶️ Check out our recently published study @FrontOncology @Eugenio74446325 @riccardoschiav6 @stefanofanti4 @Lorenzo26232839 @pietropiazza @AngeloMottaran frontiersin.org/journals/oncol…

imagination goes beyond reality

@stefanofanti4 @Uroweb @Unibo Grazie mille prof!!

@drMDrog @Uroweb @Unibo Bravo !! 👏🏻👏🏻

🏆Honored to receive this award for Best Oral Presentation, presenting our results of high risk PCa pts managed with intense obs+sRT. Thanks to everyone who supported this project, and to organizers and audience for this incredible honor 🙌 #EMUC23 @Uroweb @Unibo

@oktyzmn @Uroweb @Unibo Thank you my friend :)

@drMDrog @Uroweb @Unibo Many congrats my friend 👏 very well-deserved.

Best abstract at EMUC23 EASY-1 project at @Unibo: with intensive surveillance almost 90% of high risk PCa can avoid aRT at 3 years! Congratulations to @drMDrog

@LambAlastair @treatyOfSharma @maggiesoxford @RuthMacPherson @uro_lopez @tomleslie21 @LabBryant @OxfordCancer @OxPCaBiol @PikaRoland @PromoteStudy @mercaderclaudia @Mutieraslan @AltanOmerElvis 54% pT3 and 58% HR PCa with just 10% LND? That’s a bit of a mismatch

Excellent to have our #Oxford_Urology annual #RARP audit from @treatyOfSharma •n=175 •74% attended @maggiesoxford •0% GG1 (for 5th Yr) •54% pT3 •10% LNDs (n=20 yield) •PSM 19% (13%T2: 25.3%T3) [dropped yrly since radiol @RuthMacPherson joined planning meets] •85% Day 1 d/c

1st Edition of the Italian #ESUBootCamp - It's a wrap! A big thank you to all the trainees, the faculty, @UrowebESU @SIU_Italia @HUNIMED for making this a fantastic opportunity for young urology residents to gain hands-on training. #UrologyTraining @NBuffi @tiago_urology

Very happy to be part of the first 🇮🇹 #ESU boot camp as a trainer today. Thanks to @HUNIMED , @SIU_Italia and @UrowebESU

@DrYukselUrun @EurUrolFocus @Uroweb @OncoAlert @AmerUrological @ASTRO_org @ESTRO_RT @piet_ost @DrSpratticus @OncoBellmunt @DrShariat @GGiannarini @AlbertoBossial @apolo_andrea @UroDocAsh @Prof_Nick_James @ProfSyedHussain But how do these findings get along with those from the ProtecT where no difference in OS was noted between RP and RT?

🔍 Study finds higher rates of aggressive bladder cancer post-radiation compared to surgery. ⚠️ Bladder cancers post-radiation are more likely to be muscle invasive & sarcomatoid variant. #bladdercancer @EurUrolFocus @Uroweb @OncoAlert @AmerUrological @ASTRO_org @ESTRO_RT